Loss of the functional airway microvasculature predisposes lung transplants to chronic rejection. We investigate mechanisms associated with transplant microvascular injury as well as repair. We are interested in developing novel therapeutics to improve airway anastomosis health and long-term survival of lung transplants. Our discoveries in airway microvascular biology may also provide insights into other chronic lung diseases such as emphysema and pulmonary hypertension.